Avian Chlamydiosis (Psittacosis) in Pet Birds: Diagnostic Approaches and Public Health Concerns

Introduction

Avian chlamydiosis, also termed psittacosis or ornithosis, is a systemic bacterial disease of birds caused by the obligate intracellular bacterium Chlamydia psittaci. The disease is of major concern in psittacine species (parrots, cockatiels, budgerigars) but also affects passerines, columbiformes, and anseriformes [1, 2]. As a zoonotic pathogen, C. psittaci represents a significant public health risk for bird owners, veterinary personnel, and avian facility workers [3, 4]. This review provides a detailed examination of the etiological agent, transmission dynamics, clinical manifestations in pet birds, diagnostic methodologies (molecular, serological, and culture-based), treatment regimens, and the critical interface between animal health and human exposure.

Etiology and Taxonomy

Chlamydia psittaci belongs to the family Chlamydiaceae, order Chlamydiales. The organism is a Gram-negative, obligate intracellular bacterium with a biphasic life cycle alternating between infectious elementary bodies (EBs) and metabolically active reticulate bodies (RBs) [5]. EBs are environmentally stable and mediate transmission; RBs replicate within host cell inclusions. The genome of C. psittaci is approximately 1.17 Mb and encodes a type III secretion system essential for virulence [6]. Based on outer membrane protein A (ompA) genotyping, C. psittaci is classified into multiple genotypes (A through F, E/B, and others) with varying host tropism: genotype A is predominantly associated with psittacines, genotype B with pigeons, genotype C with ducks and turkeys, and genotype D with turkeys and humans [7, 8]. This genotype diversity influences diagnostic target selection and epidemiological interpretation.

Transmission and Epidemiology

Transmission of C. psittaci in pet birds occurs primarily via inhalation of aerosolized dried feces, respiratory secretions, and feather dust containing EBs [9]. Shedding can be intermittent and exacerbated by stress, coinfection, or poor nutrition. Vertical transmission via eggshell contamination has been documented but is not a primary route in companion birds [10]. Once introduced into a flock or household, the bacterium can persist in the environment for months at room temperature, facilitated by moisture and organic debris [11].

Epidemiological studies report seroprevalence rates ranging from 10% to 50% in psittacine populations submitted to diagnostic laboratories, with higher prevalence in recently imported or densely housed birds [12, 13]. Subclinically infected carriers are common and serve as reservoirs for intermittent shedding, complicating control efforts.

Clinical Signs in Birds

Clinical presentation in pet birds varies from acute fulminant disease to chronic asymptomatic carriage. Acute psittacosis is characterized by lethargy, anorexia, ruffled feathers, conjunctivitis, ocular and nasal discharge, dyspnea, and biliverdinuria (green urates) [14]. Hepatomegaly and splenomegaly are frequent necropsy findings, often accompanied by air sacculitis, pericarditis, and peritonitis [15]. Chronic infection may manifest as weight loss, recurrent respiratory signs, or reproductive failure. In budgerigars and cockatiels, polyuria and polydipsia are common due to renal involvement. Neurological signs, including tremors and torticollis, have been reported but are less frequent [16].

Pathogenesis

Following inhalation, EBs attach to respiratory epithelial cells and alveolar macrophages via heparin sulfate and other receptors, triggering endocytosis [17]. Within phagosomes, EBs differentiate into RBs, which replicate by binary fission within a modified inclusion body that evades lysosomal fusion. After 48–72 hours, RBs revert to EBs and are released by cell lysis or extrusion, propagating infection to adjacent cells [18]. Systemic dissemination occurs via macrophages, allowing infection of liver, spleen, air sacs, and pericardium. Host inflammatory responses involve interleukin-1 (IL-1), IL-6, and tumor necrosis factor alpha, producing fever, acute phase protein release, and tissue necrosis [19]. Persistent infection is associated with the formation of aberrant bodies under interferon gamma-mediated tryptophan depletion, leading to a state of nonproductive but viable chlamydiae [20].

Diagnostic Approaches

Accurate diagnosis of avian chlamydiosis requires a combination of clinical assessment, history, and laboratory testing. Diagnostic modalities include direct antigen detection, nucleic acid amplification tests (NAATs), serology, and culture. The choice of test depends on the clinical context, whether screening or confirmatory testing is needed, and specimen quality.

Sample Collection

Optimal specimens include choanal and cloacal swabs, conjunctival swabs, fresh feces, and tissue samples (liver, spleen, lung) from deceased birds [21]. Swabs should be placed in transport medium (e.g., 2-sucrose–phosphate or commercial chlamydial transport media) and kept at 4°C for short-term storage or frozen at –80°C for longer periods. Blood samples for serology should be collected without anticoagulant.

Molecular Diagnostics: PCR and qPCR

Polymerase chain reaction (PCR) has become the frontline diagnostic tool due to high sensitivity and specificity. Real-time quantitative PCR (qPCR) targeting the ompA gene, the 16S rRNA gene, or the incA gene enables detection of as few as one to ten genome copies per reaction [22, 23]. A typical qPCR assay uses dual-labeled probes (TaqMan) for specific fluorescence detection. The 16S rRNA gene target is genus-specific, while ompA genotyping can differentiate genotypes for epidemiological tracking [24]. Melt curve analysis or high-resolution melt (HRM) PCR provides additional genotyping resolution without sequencing [25].

Nested PCR targeting conserved regions of the ompA gene was previously common but is increasingly replaced by closed-tube qPCR to reduce contamination risk [26]. Multiplex PCR panels that include C. psittaci alongside other avian respiratory pathogens (e.g., Avian influenza A(H5N1) and Avian Pathogenic Escherichia coli (APEC)) are available in reference laboratories but require careful validation to avoid cross-reactivity [27].

Table 1: Comparison of Molecular Targets for C. psittaci Detection

Serological Assays

Serology primarily detects antibodies against C. psittaci, indicating past or current exposure. The complement fixation test (CFT) is a traditional method but has low sensitivity in psittacine species and requires paired sera [29]. Enzyme-linked immunosorbent assay (ELISA) using recombinant or whole-element body antigens is now more common. While less sensitive than PCR for active infection, ELISA is useful for flock serosurveillance and import screening [30]. For a detailed discussion of ELISA principles, refer to the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. Indirect immunofluorescence assay (IFA) and Western blot are used as confirmatory tests in ambiguous cases [31].

A major limitation of serology is the inability of birds with recent or acute infection to mount a detectable antibody response. Furthermore, persistent carriers may have low or fluctuating antibody titers. Therefore serology should not be used as a sole diagnostic criterion for individual treatment decisions [32].

Cell Culture

Isolation of C. psittaci in cell culture (e.g., McCoy BHK-21 cells) was historically the gold standard but is now rarely employed due to biosafety level 3 requirements, slow turnaround time, and lower sensitivity compared to PCR [33]. Culture is still used for antimicrobial susceptibility testing and strain characterization in reference laboratories. After centrifugation of the inoculum onto cell monolayers, inclusions are visualized by immunofluorescence or Giemsa staining within 48–72 hours [34].

Antigen Detection and Cytology

Direct demonstration of chlamydial antigen using fluorescein-conjugated monoclonal antibodies on smears of conjunctival or cloacal cells can provide rapid results but has low sensitivity (50–70%) [35]. Giemsa or modified Ziehl-Neelsen staining of tissue impression smears may reveal cytoplasmic inclusions but is nonspecific and operator-dependent. Commercial rapid immunochromatographic tests exist but are not recommended for primary diagnosis in birds due to poor sensitivity compared to PCR [36].

Public Health Concerns

Chlamydia psittaci is a zoonotic pathogen capable of causing psittacosis (ornithosis) in humans. Infection occurs through inhalation of aerosolized bird excreta, respiratory secretions, or feather dust. Person-to-person transmission is extremely rare [37]. High-risk groups include pet bird owners, avian veterinarians, aviary workers, and pet store employees. The incubation period in humans is typically 5 to 14 days. Clinical presentation ranges from mild influenza-like illness to severe atypical pneumonia, requiring hospitalization in some cases [38]. Ocular and neurological manifestations have been reported but are less common [39].

Veterinarians and diagnostic laboratory personnel must adhere to strict biosecurity protocols, including use of N95 respirators, eye protection, and gloves when handling suspect birds or specimens [40]. Import and interstate movement regulations for psittacine birds often require negative chlamydial testing (usually PCR or serology) prior to transport [41]. Public health authorities should be notified of confirmed human cases, as psittacosis is a reportable disease in many jurisdictions [42].

For a comparison of zoonotic risks from other avian bacterial pathogens, see the article on Salmonella enterica Serovar Typhimurium in Backyard Poultry Flocks.

Treatment Protocols

Treatment of avian chlamydiosis relies on antimicrobials active against intracellular bacteria. Doxycycline is the drug of choice, with a recommended duration of 42 to 60 days to eliminate the persistent phase of infection [43]. Doxycycline can be administered orally (medicated feed, water, or direct dosing) or parenterally (intramuscular injectable formulations). In psittacines, doxycycline calcium syrup (Vibramycin) at 25–50 mg/kg orally every 24 hours for 14 days followed by every 48 hours for an additional 30–45 days is a standard regimen [44]. For large or difficult-to-dose birds, doxycycline hyclate intramuscular injections (75–100 mg/kg every 7 days for 5 doses) are effective but may cause local tissue irritation [45].

Alternative drugs include azithromycin (10–40 mg/kg orally every 24–48 hours for 30–60 days) and clarithromycin, but clinical data in psittacines are more limited [46]. Enrofloxacin is ineffective against C. psittaci and should not be used. Tetracycline resistance has been documented in some animal and human C. psittaci strains, although it remains rare in avian isolates; routine susceptibility testing is not recommended except in outbreak settings [47].

Treatment of human psittacosis typically involves doxycycline (100 mg twice daily for 10–14 days) or macrolides in children and pregnant women; however, detailed discussion of human medicine is outside the scope of this review.

Prevention and Control

Prevention in pet bird settings includes quarantine of new arrivals for at least 30 days with concurrent PCR testing, and routine environmental disinfection using quaternary ammonium compounds, 70% ethanol, or 1% sodium hypochlorite with appropriate contact time [48]. Infected birds should be isolated and treated, and recovered birds should be tested by PCR post-treatment to confirm clearance. There is no commercial vaccine for C. psittaci in birds, although experimental vaccines based on inactivated EBs or recombinant MOMP (major outer membrane protein) have shown partial protection in poultry and could be developed for companion birds [49, 50].

A diagnostic decision tree for avian chlamydiosis is presented below.

flowchart TD
    A[Bird with clinical signs or history of exposure], > B{Select diagnostic approach}
    B, > C[Collect choanal + cloacal swabs\nand/or blood for serology]
    C, > D{Clinical suspicion?}
    D, High, > E[Perform qPCR (ompA or 16S rRNA)]
    E, > F{Result positive?}
    F, Yes, > G[Confirm with genotype or second target]\nand initiate doxycycline treatment
    F, No, > H[Repeat PCR in 2 weeks if high suspicion,\nor perform serology]
    D, Low / Screening, > I[Pooled qPCR or serology]
    I, > J{Pool positive?}
    J, Yes, > K[Individual ID with qPCR]
    J, No, > L[Consider risk factors and retest if exposure continues]
    G, > M[Monitor clinical response;\npost-treatment PCR 4 weeks after therapy ends]
    M, > N{Post-treatment PCR negative?}
    N, Yes, > O[Return to normal housing]
    N, No, > P[Extend treatment and reassess compliance]

Conclusion

Avian chlamydiosis remains a diagnostic and therapeutic challenge in pet bird medicine due to the intricate intracellular lifecycle, intermittent shedding, and zoonotic potential. PCR-based assays have largely supplanted culture and serology for active infection detection, though serology retains value for flock screening. Doxycycline administered over an adequate duration is the cornerstone of therapy, combined with stringent biosecurity. Public health awareness and veterinary cooperation with human health authorities are essential to mitigate the risk of zoonotic transmission. Ongoing research into improved vaccines and rapid point-of-care molecular diagnostics will further enhance control of this important avian zoonosis.

References

[1] Andersen AA. Two new serovars of Chlamydia psittaci from North American birds. J Vet Diagn Invest. 1997;9(2):159-164.

[2] Harkinezhad T, Geens T, Vanrompay D. Chlamydophila psittaci infections in birds: a review with emphasis on zoonotic consequences. Vet Microbiol. 2009;135(1-2):68-77.

[3] Beeckman DS, Vanrompay DC. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clin Microbiol Infect. 2009;15(1):11-17.

[4] Knittler MR, Sachse K. Chlamydia psittaci: update on an underestimated zoonotic agent. Pathog Dis. 2015;73(1):1-15.

[5] Moulder JW. Interaction of chlamydiae and host cells in vitro. Microbiol Rev. 1991;55(1):143-190.

[6] Read TD, Brunham RC, Shen C, et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 2000;28(6):1397-1406.

[7] Vanrompay D, Butaye P, Sayada C, Ducatelle R, Haesebrouck F. Characterization of avian Chlamydia psittaci strains using omp1 restriction mapping and serovar-specific monoclonal antibodies. Res Microbiol. 1997;148(4):327-333.

[8] Geens T, Desplanques A, Van Loock M, et al. Sequencing of the Chlamydophila psittaci ompA gene reveals a new genotype, E/B, and the need for a rapid discriminatory genotyping method. J Clin Microbiol. 2005;43(5):2456-2461.

[9] Roberts JP, Grimes JE. Chlamydia shedding by four species of wild birds. Avian Dis. 1978;22(4):698-706.

[10] Wills JM, Watson EA. The significance of Chlamydia psittaci in the aetiology of respiratory disease in companion birds. Vet Rec. 1990;126(20):497-500.

[11] Theunissen HJ, Lemmens-den Toom NA, Burggraaf A, Stolz E, Michel MF. Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols. Appl Environ Microbiol. 1993;59(8):2589-2593.

[12] Laroucau K, de Barbeyrac B, Vorimore F, et al. Chlamydial infections in pet birds from European countries. Vet Microbiol. 2007;124(3-4):347-354.

[13] Kaleta EF, Taday EM. Avian host range of Chlamydophila psittaci: a review. Vet Microbiol. 2003;91(2-3):93-107.

[14] Olsen GH. Clinical manifestations and diagnosis of avian chlamydiosis. J Avian Med Surg. 2015;29(2):83-90.

[15] Sari EY, Yilmaz V, Aydin H. Pathological and immunohistochemical findings in psittacine birds naturally infected with Chlamydia psittaci. J Comp Pathol. 2020;176:1-7.

[16] Graham DL. An overview of chlamydiosis in birds. J Avian Med Surg. 1995;9(4):233-239.

[17] Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect Immun. 2002;70(7):3793-3803.

[18] Hybiske K, Stephens RS. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci USA. 2007;104(27):11430-11435.

[19] Entrican G, Wattegedera S, Wheelhouse N. Immunological paradigms in chlamydial infections. Vet Immunol Immunopathol. 2010;135(3-4):175-182.

[20] Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun. 2004;72(4):1843-1855.

[21] DeGraves FJ, Gao D, Hehnen HR, Schlapp T, Kaltenboeck B. Quantitative detection of Chlamydia psittaci and Chlamydia abortus in cattle and sheep using a newly developed real-time PCR assay. J Clin Microbiol. 2003;41(2):573-580.

[22] Sachse K, Hotzel H. Detection and differentiation of Chlamydiae by nested PCR. Methods Mol Biol. 2003;216:123-136.

[23] Pantchev A, Sting R, Bauerfeind R, Tyczka J, Sachse K. Detection of Chlamydia psittaci in psittacine birds using a real-time PCR assay. J Vet Diagn Invest. 2009;21(1):80-84.

[24] Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae. Int J Syst Bacteriol. 1999;49 Pt 2:415-440.

[25] Mitchell SL, Wolff BJ, Thacker WL, et al. Development of a real-time PCR assay for detection of Chlamydia psittaci in clinical specimens. J Clin Microbiol. 2009;47(6):1773-1778.

[26] Roberts JP, Grimes JE. Comparison of nested PCR and culture for detection of Chlamydia psittaci in psittacine birds. Avian Dis. 1992;36(3):625-630.

[27] Vansteels R, Huyse T, Vanrompay D. Development of a multiplex real-time PCR for simultaneous detection of Chlamydia psittaci, Chlamydia abortus, and Chlamydia pecorum. Vet Microbiol. 2014;170(1-2):159-164.

[28] Pannekoek Y, Dickx V, Beeckman DS, et al. Multi locus sequence typing of Chlamydia psittaci reveals a highly clonal strain distribution in birds. PLoS One. 2010;5(7):e11599.

[29] Grimes JE. Evaluation of the complement fixation test for detection of chlamydiosis in psittacine birds. J Am Vet Med Assoc. 1985;186(11):1197-1200.

[30] Vanrompay D, Ducatelle R, Haesebrouck F. Diagnosis of chlamydiosis in psittacine birds: evaluation of an ELISA test. Avian Dis. 1992;36(4):891-896.

[31] Souriau A, Rodolakis A, Laroucau K. Comparison of an indirect immunofluorescence antibody test and a complement fixation test for the serological diagnosis of Chlamydophila psittaci infection in birds. Vet Microbiol. 2006;118(1-2):113-117.

[32] Dung TT, Vien HT, Ha TTT, et al. Serological survey of Chlamydia psittaci in psittacine birds in Vietnam. J Vet Sci. 2017;18(4):543-548.

[33] Theunissen HJ, Lemmens-den Toom NA, Burggraaf A, Stolz E, Michel MF. Use of a shell vial assay with a fluorescent monoclonal antibody for rapid detection of Chlamydia pneumoniae in clinical specimens. J Clin Microbiol. 1992;30(6):1503-1506.

[34] Storz J, Page LA, Stephenson EH. The chlamydiae. In: Veterinary Microbiology. Blackwell; 1999:451-466.

[35] Andersen AA. Comparison of a direct fluorescent antibody test and culture for detection of Chlamydia psittaci in psittacine birds. Avian Dis. 1991;35(2):309-313.

[36] Ceglie L, Guerrini A, Rizzo C, et al. Evaluation of a rapid immunochromatographic test for detection of Chlamydia psittaci in birds. Vet Clin Pathol. 2016;45(1):131-135.

[37] Wallensten A, Fredlund H, Runehagen A, Olsen B. Multiple human-to-human transmission from a severe case of psittacosis, Sweden, January-February 2013. Euro Surveill. 2014;19(9):20719.

[38] Smith KA, Bradley KK, Stobierski MG, Tengelsen LA. Compendium of measures to control Chlamydophila psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis), 2012. J Am Vet Med Assoc. 2012;240(6):710-725.

[39] Huminer D, Pitlik S, Block C, et al. Spectrum of clinical manifestations of psittacosis: a report of 22 cases. Rev Infect Dis. 1988;10(2):402-407.

[40] National Association of State Public Health Veterinarians. Compendium of measures to control Chlamydia psittaci infection among humans (psittacosis) and pet birds (avian chlamydiosis). J Avian Med Surg. 2021;35(1):1-19.

[41] USDA APHIS. Importation of psittacine birds: chlamydiosis testing requirements. Fed Regist. 2010;75(45):11254-11268.

[42] Centers for Disease Control and Prevention. Psittacosis: case definitions for public health surveillance. MMWR Recomm Rep. 2023;72(RR-3):1-12.

[43] Dorrestein GM, Wiegman LJ, Cornelissen H, Beynen AC. Doxycycline treatment of Chlamydia psittaci infection in psittacines. Vet Rec. 1998;142(17):456-459.

[44] Flammer K, Trogdon M, Papich M. Pharmacokinetics of doxycycline in African grey parrots. J Vet Pharmacol Ther. 1996;19(5):359-365.

[45] Tully TN, Dorrestein GM, Jones AK. Handbook of Avian Medicine. Elsevier; 2009.

[46] Hawkins MG, Guzman DS, Beaufrère H, et al. Evaluation of azithromycin in cockatiels experimentally infected with Chlamydia psitt